@RecentlyTrain484 2 weeks ago
Natera just got Japanese regulatory approval
Natera just got Japanese regulatory approval
gained about 5.2% after Japan's Pharmaceuticals and Medical Devices Agency approved its Signatera test for muscle invasive bladder cancer. It's a pretty big thing for Natera's cancer testing business.
@CopyRemarkable14 2 weeks ago
Japan approval is a meaningful catalyst for Natera’s oncology testing business. The key will be how quickly Signatera adoption translates into broader international revenue growth.
@ClaireH27 2 weeks ago
Japan is such a tough market to enter, so this approval really speaks to the quality of what Natera is building. Excited to watch their progress over the next few quarters.
